Aro R, Mäkäräinen-Uhlbäck E, Ämmälä N, et al. - Researchers examined if and how sarcopenia or myosteatosis affect short- and long-term results in patients who were surgically treated for colorectal cancer. They assessed 348 curatively treated colorectal cancer patients during 2007–2011 in this study. Among these, 208 patients (59.8%) had sarcopenia and 108 patients (31.2%) had myosteatosis. Outcomes suggest that pneumonia and cardiorespiratory complication rates increase with sarcopenia. The requirement for institutional care after colorectal cancer surgery may be predicted with sarcopenia and myosteatosis. They identified sarcopenia and myosteatosis negatively affect colorectal cancer patients’ survival. An independent risk factor for poor overall 5-year survival was myosteatosis.